In this recorded discussion on the diagnosis and clinical management of late endocrine effects in pediatric and adult cancer survivors, hear expert perspectives on:
This course was a virtual live CME-certified Ancillary Symposium developed in collaboration with our partner - Clinical Care Options (CCO) to be presented at ENDO 2021. This educational activity is supported by an independent medical educational grant from Novo Nordisk Inc. This ancillary symposium is developed through the Endocrine Society’s Special Programs Committee (SPC).
Click the button(s) below to open the related ClinicalThought commentaries:
Upon successful completion these educational sessions, participants should be better able to:
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.
Maintenance of Certification (MOC) - if eligibleSuccessful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.50 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.orgJoint Accreditation StatementIn support of improving patient care, this activity has been planned and implemented by The Endocrine Society and Clinical Care Options, LLC (CCO). Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Education Credit Designation
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. For questions about obtaining Nursing credit, please contact Sophia Kelley at skelley@clinicaloptions.com.
Continuing Pharmacy Education Credit DesignationCCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-21-017-L01-P.
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
For questions about obtaining Pharmacy credit, please contact Sophia Kelley at skelley@clinicaloptions.com.
Wassim Chemaitilly, MD - Program ChairAssociate Member, St. Jude FacultyDirector, Endocrinology DivisionSt. Jude Children’s Research HospitalMemphis, TN
Laurie E. Cohen, MDDirector of the Neuroendocrinology ProgramDirector of the Growth Program Director of Clinical Innovation and Digital Health, Division of EndocrinologyBoston Children’s HospitalBoston, MA
Danielle N. Friedman, MD, MSPediatric Long-Term Follow-Up ProgramDepartment of PediatricsMemorial Sloan Kettering Cancer CenterNew York, NY
Steven G. Waguespack, MDProfessor of Internal Medicine and Pediatrics University of Texas MD Anderson Cancer CenterHouston, TX
STATEMENT OF INDEPENDENCEAs a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.
DISCLOSURE POLICYThe faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:Laurie E. Cohen, MD: Research Investigator, Pfizer, Inc.; Speaker, Novo Nordisk; Other, SandozDanielle N. Friedman, MD, MS: Advisory Board Member, Fennec
The following faculty reported no relevant financial relationships during the content development process for this activity: Wassim Chemaitilly, MD; Steven G. Waguespack, MD
The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships: Beret Anne Casey, MD
The following SPC Committee members reported financial relationships:
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The following SPC members reported no relevant financial relationships:
Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Kelly Lauter Roszko, MD, PhD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD
The staff involved in the development of this CME activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORTThis activity is supported by an educational grant from Novo Nordisk, Inc.